NIH-funded research R01 grant

Investigating the use and effects of new psychoactive substances among NYC nightlife attendees

Official title: New psychoactive substance exposure among NYC nightclub and festival attendees

Funded at New York University School of Medicine · NIH-11085183 · Data updated 2026-11-12

This study is looking at how common new drugs are at electronic dance music events in New York City and how they affect people, especially those who might not know what they're taking, to help improve safety and prevent overdoses.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 15, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$671,181
NIH project number5R01DA057289-03
Project IDNIH-11085183 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include individuals aged 21 and older who attend electronic dance music events and may be exposed to new psychoactive substances.

Less likely to help

Patients who do not attend nightlife events or are not exposed to new psychoactive substances may not benefit from this research.

What this research studies

This research focuses on understanding the prevalence and effects of new psychoactive substances (NPS) among attendees of electronic dance music events in New York City. By employing advanced toxicology methods and epidemiological surveys, the study aims to gather data on drug exposure and its consequences, particularly among individuals who may be unaware of the substances they are consuming. The findings will provide critical insights into trends in drug use and help inform public health strategies to prevent overdoses and related adverse outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention strategies and interventions that reduce drug-related harm and fatalities among nightlife attendees and the broader community.

How similar studies have gone: Previous research has shown success in using similar epidemiological and toxicological approaches to understand drug use trends and their impacts.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Palamar, Joseph J — New York University School of Medicine
  • Study coordinator: Palamar, Joseph J

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.